Cargando…
Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure
BACKGROUND: Metronidazole is the first-line treatment for bacterial vaginosis, but cure rates are suboptimal and recurrence rates high. OBJECTIVES: To evaluate the impact of a standard course of oral metronidazole treatment (500 mg twice per day for 7 days) on the vaginal microbiota of Rwandan bacte...
Autores principales: | Verwijs, Marijn C., Agaba, Stephen K., Darby, Alistair C., van de Wijgert, Janneke H.H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995998/ https://www.ncbi.nlm.nih.gov/pubmed/31404542 http://dx.doi.org/10.1016/j.ajog.2019.08.008 |
Ejemplares similares
-
Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing
por: van de Wijgert, Janneke H. H. M., et al.
Publicado: (2020) -
Vaginal probiotic adherence and acceptability in Rwandan women with high sexual risk participating in a pilot randomised controlled trial: a mixed-methods approach
por: Verwijs, Marijn C, et al.
Publicado: (2020) -
Pathobionts in the Vaginal Microbiota: Individual Participant Data Meta-Analysis of Three Sequencing Studies
por: van de Wijgert, Janneke H. H. M., et al.
Publicado: (2020) -
Evaluation of Lysis Methods for the Extraction of Bacterial DNA for Analysis of the Vaginal Microbiota
por: Gill, Christina, et al.
Publicado: (2016) -
The vaginal microbiome and sexually transmitted infections are interlinked: Consequences for treatment and prevention
por: van de Wijgert, Janneke H. H. M.
Publicado: (2017)